- Home
- VRNA vs ESBA Comparison
VRNA vs ESBA Comparison
Compare VRNA & ESBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRNA
- ESBA
- Stock Information
- Founded
- VRNA 2005
- ESBA N/A
- Country
- VRNA United Kingdom
- ESBA United States
- Employees
- VRNA N/A
- ESBA N/A
- Industry
- VRNA Biotechnology: Pharmaceutical Preparations
- ESBA
- Sector
- VRNA Health Care
- ESBA
- Exchange
- VRNA Nasdaq
- ESBA NYSE
- Market Cap
- VRNA 3.4B
- ESBA 2.9B
- IPO Year
- VRNA 2017
- ESBA 2013
- Fundamental
- Price
- VRNA $51.89
- ESBA $9.63
- Analyst Decision
- VRNA Strong Buy
- ESBA
- Analyst Count
- VRNA 7
- ESBA 0
- Target Price
- VRNA $50.57
- ESBA N/A
- AVG Volume (30 Days)
- VRNA 1.4M
- ESBA 11.5K
- Earning Date
- VRNA 02-27-2025
- ESBA 01-01-0001
- Dividend Yield
- VRNA N/A
- ESBA 1.45%
- EPS Growth
- VRNA N/A
- ESBA N/A
- EPS
- VRNA N/A
- ESBA 0.27
- Revenue
- VRNA $5,624,000.00
- ESBA $758,432,000.00
- Revenue This Year
- VRNA N/A
- ESBA N/A
- Revenue Next Year
- VRNA $550.30
- ESBA N/A
- P/E Ratio
- VRNA N/A
- ESBA $35.64
- Revenue Growth
- VRNA 1127.95
- ESBA 4.19
- 52 Week Low
- VRNA $11.39
- ESBA $7.85
- 52 Week High
- VRNA $55.42
- ESBA $11.50
- Technical
- Relative Strength Index (RSI)
- VRNA 64.25
- ESBA 41.97
- Support Level
- VRNA $43.44
- ESBA $9.30
- Resistance Level
- VRNA $55.42
- ESBA $9.51
- Average True Range (ATR)
- VRNA 3.32
- ESBA 0.30
- MACD
- VRNA 0.40
- ESBA -0.03
- Stochastic Oscillator
- VRNA 70.52
- ESBA 26.22
About VRNA Verona Pharma plc
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.
About ESBA EMPIRE STATE REALTY OP LIM PARTNER
Empire State Realty OP LP is the operating partner of Empire State Realty Inc. The company along with its partner manages, operates, acquires and repositions properties in Manhattan and the greater New York metropolitan area. The firm operates in two segments, Real Estate and Observatory. Through the Real Estate segment, it offers services related to the ownership, management, operation, acquisition, repositioning and disposition of its real estate assets. Under the Observatory segment, it operates the two observatories of the Empire State Building. The company generates maximum revenue from the Real Estate segment.